• Top in hem/onc: Cord blood, regulatory T-cell therapy

    9 days ago - By Healio

    A novel reduced-intensity conditioning regimen paired with umbilical cord blood appeared to be effective against several genetic noncancerous disorders, according to a recent study. It was the top story in hematology/oncology last week.
    Another top story was about the therapeutic potential of regulatory T cells against COVID-19-related respiratory distress.
    Read these and more top stories in hematology/oncology below:
    Cord blood may be effective for treatment of 20 pediatric disorders
    Hematopoietic stem cell transplantation has proved effective for the treatment of many inherited
    Read more ...